List of validated methods-mar-2013.xls

LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Clarithromycin / Clarithromycin 14-Hydroxy Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Antiinflamatory, Antibacterial, Antimalarial Diltiazem / Diltiazem Desacetyl / Diltiazem Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Ezetemibe (Free) / Ezetemibe Glucouronide Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Mycophenolic Acid / Mycophenolate Mofetil Anti-obesity (gastric and pancreatic lipase Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Anti-obesity (gastric and pancreatic lipase Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF DIFFICULT BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Antiinflamatory, Antibacterial, Antimalarial Mycophenolic Acid / Mycophenolate Mofetil Anti-obesity (gastric and pancreatic lipase inhibitor)Anti-obesity (gastric and pancreatic lipase Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF DIFFICULT BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS UNDER DEVELOPMENT AT FORTIS CLINICAL RESEARCH LIMITED LLOQ (per mL) Instrument Theraputic Classification Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.

Source: http://www.fortis-cro.com/pdf/list-of-validated-methods-jun-2012.pdf

Le vcu du patient parkinsonien ayant bnfici d'une greffe intra-crbrale d'embryons humains

Le vécu du patient parkinsonien ayant bénéficié d'une greffe intra-cérébrale d'embryons humains LOPES Manuel RESUME La greffe cérébrale de cellules embryonnaires dans la maladie de Parkinson à un stade évolué, est une approche thérapeutique innovante et prometteuse, mais au demeurant hasardeuse car elle risque d' occulter le patient au bénéfice d' une étude spécifique de la

Microsoft word - idts needs assessment 2008-09.doc

HMP LEEDS INTEGRATED DRUG TREATMENT SYSTEM NEEDS ASSESSMENT OF TREATMENT DEMAND Author: Lydia Mwanje (Commissioning Support Officer) Safer Leeds Commissioning Team Whilst every care has been taken to ensure the accuracy of the data, it is supplied on the condition that employees of Leeds City Council and Leeds Primary Care Trust cannot be held responsible for any error, o

Copyright © 2010-2014 Medical Pdf Finder